Author Archives for Samantha Floyd

Humanigen and Lonza Announce Collaboration to Expand Manufacturing of Humanigen’s COVID-19 Therapeutic Candidate Lenzilumab

September 16, 2020 3:38 pm Published by Leave your thoughts

Humanigen, a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper response called ‘cytokine storm,’ and Lonza today announced a strategic collaboration to expand the manufacturing capacity for lenzilumab, currently in Phase 3 clinical trials for COVID-19, in advance of potential Emergency Use Authorization in 2020 and subsequent commercialization.


Lonza’s Ibex Dedicate to Support the Commercial Manufacture of Kodiak’s KSI-301 – an Antibody Biopolymer Conjugate for Retinal Diseases

August 10, 2020 8:15 am Published by Leave your thoughts

Kodiak Sciences, a clinical-stage biopharmaceutical company specializing in novel ophthalmic therapies, and Lonza announced today that the companies have signed a long-term contract for manufacturing KSI-301, an Antibody Biopolymer Conjugate (ABC) that is a potential first-line treatment for retinal vascular diseases.